| GRCh37/hg19 position | 10:43615094 |
| GRCh38/hg38 position | 10:43119646 |
| Alleles (ref/alt) | C/T |
| dbSNP rsid | rs1800862 |
| Gene symbol |
RET |
| Most severe consequence | synonymous_variant |
| Flanking sequence | ACCTGGGCAGTGGAGGCAGCCGCAACTCCAG[C/T]TCCCTGGACCACCCGGATGAGCGGGCCCTCA |
| HGVS |
NM_001355216.1:c.1746C>T NM_020630.6:c.2508C>T NM_020975.6:c.2508C>T |
| Transcript | Gene | Exon number | Consequence | HGVS cDNA | HGVS protein | Location | Protein location | ||||
| NM_001355216.1 | RET | 16 | synonymous_variant | c.1746C>T | p.Ser582= | Exon 11 |
|
||||
| NM_020630.6 | RET | 19 | synonymous_variant | c.2508C>T | p.Ser836= | Exon 14 |
|
||||
| NM_020975.6 | RET | 20 | synonymous_variant | c.2508C>T | p.Ser836= | Exon 14 |
|
| Database | Population | AC | AN | Hom | AF |
| 1000 genomes | ALL | 180 | 5008 | - | 0.0359425 |
| EUR | - | - | - | 0.0586 | |
| EAS | - | - | - | 0 | |
| SAS | - | - | - | 0.0849 | |
| AFR | - | - | - | 0.0129 | |
| AMR | - | - | - | 0.0303 | |
| ExAC | ALL | 5527 | 118460 | 188 | 0.046657 |
| FIN | 230 | 6484 | 4 | 0.035472 | |
| NFE | 3173 | 64670 | 76 | 0.049064 | |
| EAS | 13 | 8546 | 0 | 0.001521 | |
| SAS | 1568 | 16506 | 99 | 0.094996 | |
| AFR | 242 | 9938 | 2 | 0.024351 | |
| AMR | 258 | 11442 | 6 | 0.022549 | |
| OTH | 43 | 874 | 1 | 0.049199 | |
| gnomAD genomes | ALL | 1052 | 30898 | 25 | 0.0340475 |
| FIN | 117 | 3494 | 3 | 0.033486 | |
| NFE | 650 | 14956 | 20 | 0.0434608 | |
| ASJ | 13 | 302 | 0 | 0.0430464 | |
| EAS | 1 | 1622 | 0 | 0.000616523 | |
| AFR | 216 | 8706 | 2 | 0.0248105 | |
| AMR | 19 | 838 | 0 | 0.022673 | |
| OTH | 36 | 980 | 0 | 0.0367347 | |
| gnomAD exomes | ALL | 11131 | 245364 | 362 | 0.0453653 |
| FIN | 758 | 22250 | 16 | 0.0340674 | |
| NFE | 5535 | 111044 | 137 | 0.0498451 | |
| ASJ | 533 | 9832 | 8 | 0.0542107 | |
| EAS | 15 | 17214 | 0 | 0.000871384 | |
| SAS | 2916 | 30780 | 180 | 0.0947368 | |
| AFR | 355 | 15212 | 2 | 0.0233368 | |
| AMR | 765 | 33564 | 15 | 0.0227923 | |
| OTH | 254 | 5468 | 4 | 0.0464521 | |
| CONVERGE | ALL | - | - | - | 0.002 |
| HRC | ALL | 3257 | 64976 | - | 0.0501262 |
| Method | Score | Level |
| GERP++ | 2.51 | Conserved |
| phastCons46way primates | 0.913 | Highly conserved |
| phastCons46way placental | 1.000 | Highly conserved |
| phastCons100way vertebrates | 1.000 | Highly conserved |
| phyloP46way primates | 0.313 | Not conserved |
| phyloP46way placental | 0.262 | Not conserved |
| phyloP100way vertebrates | 2.608 | Not conserved |
| Accession | Clinical significance | Date last evaluated | Review status | Method | Disease name | Disease symbol | Disease inheritance | Pubmed |
|---|---|---|---|---|---|---|---|---|
| RCV000151741 | Benign | 2023-08-15 | criteria provided, multiple submitters, no conflicts | clinical testing | not specified | - | - | |
| RCV001080523 | Benign | 2025-02-04 | criteria provided, multiple submitters, no conflicts | clinical testing | Multiple endocrine neoplasia, type 2 | MEN2 | - | |
| RCV000359214 | Likely benign | 2017-04-27 | criteria provided, single submitter | clinical testing | Renal hypodysplasia/aplasia 1 | RHDA1 | - | - |
| RCV000327711 | Likely benign | 2017-04-27 | criteria provided, single submitter | clinical testing | Pheochromocytoma | - | - | - |
| RCV000712296 | Benign/Likely benign | 2020-12-18 | criteria provided, multiple submitters, no conflicts | not provided | not provided | - | - | |
| RCV001015789 | Benign | 2019-05-07 | criteria provided, single submitter | clinical testing | Hereditary cancer-predisposing syndrome | - | - | - |
| RCV000264509 | Likely benign | 2017-04-27 | criteria provided, single submitter | clinical testing | Hirschsprung disease, susceptibility to, 1 | - | - | - |
| RCV003315509 | Benign | 2023-07-07 | criteria provided, single submitter | clinical testing | Multiple endocrine neoplasia type 2B | - | - | |
| RCV000203081 | Benign/Likely benign | 2017-04-27 | criteria provided, multiple submitters, no conflicts | clinical testing | Multiple endocrine neoplasia | - | - | - |
InterVar is a software tool for clinical interpretation of genetic variants by the ACMG/AMP 2015 guideline. The eveidence tags that variant met are highlighted. Please note that evidence tags with need to be evaluated manually.
| Benign | Pathogenic | |||||
|---|---|---|---|---|---|---|
| Strong | Supporting | Supporting | Moderate | Strong | Very Strong | |
| Population data | BA1 BS1 BS2 |
PM2 | PS4 | |||
| Computational and predictive data | BP1 BP3 BP4 BP7 |
PP3 | PM4 PM5 |
PS1 | PVS1 | |
| Functional data | BS3 | PP2 | PM1 | PS3 | ||
| Segregation data | BS4 | PP1 | PP1 | PP1 | ||
| De novo data | PM6 | PS2 | ||||
| Allelic data | BP2 | PM3 | ||||
| Other database | BP6 | PP5 | ||||
| Other data | BP5 | PP4 | ||||